Evidence map›Paper›PMID 35052613›Full record

ReviewAntioxidants (Basel, Switzerland)2022

Plant-Based Polyphenols: Anti-

María Guerra-Valle, Patricio Orellana-Palma, Guillermo Petzold

Abstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Comparative Phytochemical Analysis of the Aerial Parts ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Gut microbiota therapy in gastrointestinal diseases.Frontiers in cell and developmental biology · 2025
    Review
  10. Diseases (Basel, Switzerland) · 2024
    Review
  11. Anti-Evidence-based complementary and alternative medicine : eCAM · 2024
    Article
  12. A review for non-antibiotic treatment ofFrontiers in microbiology · 2024
    Review
  13. Review
  14. Article
  15. Frontiers in microbiology · 2023
    Review
  16. Review
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

María Guerra-VallePrograma de Doctorado en Ingeniería de Alimentos, Universidad del Bío-Bío, Av. Andrés Bello 720, Chillan 3780000, Chile.
Patricio Orellana-PalmaDepartamento de Ingeniería en Alimentos, Facultad de Ingeniería, Universidad de La Serena, Av. Raúl Bitrán 1305, La Serena 1700000, Chile.ORCID 0000-0002-7644-7509
Guillermo PetzoldLaboratorio de Crioconcentración, Departamento de Ingeniería en Alimentos, Universidad del Bío-Bío, Av. Andrés Bello 720, Chillan 3780000, Chile.ORCID 0000-0002-6924-7816

Funding

Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT) FONDECYT Postdoctoral Grant 2019 (Folio 3190420)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bioactive compoundsgut microbiotaHelicobacter pylori

Identifiers

PMID35052613
PMCPMC8772845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.